Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Ufp Technologies (UFPT) Long-Term Debt Issuances (2013 - 2018)

Ufp Technologies posted quarterly Long-Term Debt Issuances of -$16.0 million for Q3 2018, down 200.0% on a QoQ basis from $16.0 million in Q2 2018.

Ufp Technologies (UFPT) has 2 years of Long-Term Debt Issuances data on file, last reported at -$16.0 million in Q3 2018.

  • For the quarter ending Q3 2018, Long-Term Debt Issuances changed N/A year-over-year to -$16.0 million; the trailing twelve-month figure through Dec 2024 stood at -$16.0 million (changed N/A YoY), and the FY2024 full-year result was $125.0 million, changed N/A from the prior year.
  • Long-Term Debt Issuances for Q3 2018 stood at -$16.0 million, down from $16.0 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $20.0 million in Q1 2018 and bottomed at -$16.0 million in Q3 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 19.86 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 11.71 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 1.15 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Ufp Technologies 1.69 Bn 1.67 Bn 44.36 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2018 -16.00 Mn
Sep 30, 2018 -16.00 Mn
Jun 30, 2018 16.00 Mn
Jun 30, 2018 16.00 Mn
Mar 31, 2018 20.00 Mn
Mar 31, 2018 20.00 Mn
Mar 31, 2013 580,000.00
Mar 31, 2013 580,000.00